The integrity of clinical trials depends on accurate and reliable data, making the protection of endpoints a critical aspect of the entire process. Endpoints, which are specific outcomes used to measure the effectiveness of an intervention, must be safeguarded to ensure the validity and credibility of the trial results. Endpoint protection is particularly important in rare disease trials as these studies often involve small patient populations and face distinct methodological challenges. Every data point is essential to the success of the study.
This webinar explores strategies to build a comprehensive approach to endpoint protection in rare disease clinical trials, thereby ensuring the integrity and reliability of study outcomes.
Topics Include:
- Agency guidance and reference
- Strategies for ensuring quality CRO oversight of clinical data
- The role of technology and data visibility in driving informed decision-making
- Real-world case studies demonstrating the value of proactive endpoint protection
Speaker:
Angi Robinson
Senior Vice President, Specialty Areas, Premier Research
